Basic Information
LncRNA/CircRNA Name | UPAT |
Synonyms | AOC4P, AOC4, UPAT |
Region | GRCh38_17:42865922-42874369 |
Ensemble | ENSG00000260105 |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qRT-PCR, Western blot assay, luciferase reporter assay |
Sample | The human lung epithelial cell line (BEAS-2B) and NSCLC cell lines(H1299, H1650, H358 and A549), tumor tissues and matched normal tissues |
Expression Pattern | up-regulated |
Function Description | lncRNA UPAT expression was upregulated in NSCLC tissues and significantly associated with tumor size and Tumor-Node-Metastasis stage. Furthermore, UPAT promoted NSCLC cell proliferation, partly via increasing UHRF1 expression and consequently epigenetically silencing RASSF1 and CDH13 transcription. In addition, the knockdown of UHRF1 partially decreased the promotion of cell growth and G1-S phase transition caused by UPAT overexpression. |
Pubmed ID | 30008828 |
Year | 2018 |
Title | Long noncoding RNA UPAT promoted cell proliferation via increasing UHRF1 expression in non-small cell lung cancer. |
External Links
Links for UPAT | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |